Literature DB >> 12242181

Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis.

Dean Fergusson1, Shawn D Aaron, Gordon Guyatt, Paul Hébert.   

Abstract

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh：

Year:  2002        PMID： 12242181      PMCID： PMC1124168          DOI： 10.1136/bmj.325.7365.652

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  16 in total

Review 1.  New strategies for clinical trials in patients with sepsis and septic shock.

Authors:  J Cohen; G Guyatt; G R Bernard; T Calandra; D Cook; D Elbourne; J Marshall; A Nunn; S Opal
Journal:  Crit Care Med       Date:  2001-04       Impact factor: 7.598

Review 2.  Intention-to-treat analysis: implications for quantitative and qualitative research.

Authors:  D J Newell
Journal:  Int J Epidemiol       Date:  1992-10       Impact factor: 7.196

3.  Analysis of clinical trials by treatment actually received: is it really an option?

Authors:  Y J Lee; J H Ellenberg; D G Hirtz; K B Nelson
Journal:  Stat Med       Date:  1991-10       Impact factor: 2.373

Review 4.  The qualification and disqualification of patients and events in long-term cardiovascular clinical trials.

Authors:  M Gent; D L Sackett
Journal:  Thromb Haemost       Date:  1979-02-28       Impact factor: 5.249

5.  Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial.

Authors:  I G Stiell; P C Hébert; G A Wells; K L Vandemheen; A S Tang; L A Higginson; J F Dreyer; C Clement; E Battram; I Watpool; S Mason; T Klassen; B N Weitzman
Journal:  Lancet       Date:  2001-07-14       Impact factor: 79.321

6.  On estimating efficacy from clinical trials.

Authors:  A Sommer; S L Zeger
Journal:  Stat Med       Date:  1991-01       Impact factor: 2.373

7.  Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.

Authors:  C J Fisher; J F Dhainaut; S M Opal; J P Pribble; R A Balk; G J Slotman; T J Iberti; E C Rackow; M J Shapiro; R L Greenman
Journal:  JAMA       Date:  1994-06-15       Impact factor: 56.272

Review 8.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

Authors:  R C Bone; R A Balk; F B Cerra; R P Dellinger; A M Fein; W A Knaus; R M Schein; W J Sibbald
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

9.  Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer.

Authors:  J G Houbiers; A Brand; L M van de Watering; J Hermans; P J Verwey; A B Bijnen; P Pahlplatz; M Eeftinck Schattenkerk; T Wobbes; J E de Vries
Journal:  Lancet       Date:  1994-08-27       Impact factor: 79.321

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640
View more
  184 in total

1.  Pleasing some of the people none of the time.

Authors:  Paul Hilton; Karen L Ward
Journal:  BMJ       Date:  2002-12-07

2.  How to spot bias and other potential problems in randomised controlled trials.

Authors:  S C Lewis; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-02       Impact factor: 10.154

Review 3.  How to assess epidemiological studies.

Authors:  J H Zaccai
Journal:  Postgrad Med J       Date:  2004-03       Impact factor: 2.401

4.  Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis.

Authors:  Nasim A Khan; Juan I Lombeida; Manisha Singh; Horace J Spencer; Karina D Torralba
Journal:  Arthritis Rheum       Date:  2012-07

5.  Long-term exercise improves functional impairment but not quality of life in multiple sclerosis.

Authors:  Anders Romberg; Arja Virtanen; Juhani Ruutiainen
Journal:  J Neurol       Date:  2005-03-16       Impact factor: 4.849

Review 6.  Managing the baby with a patent ductus arteriosus. More questions than answers?

Authors:  P W Fowlie
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-05       Impact factor: 5.747

7.  Evaluation of a high school peer group intervention for at-risk youth.

Authors:  Hyunsan Cho; Denise Dion Hallfors; Victoria Sánchez
Journal:  J Abnorm Child Psychol       Date:  2005-06

8.  Efficacy vs effectiveness trial results of an indicated "model" substance abuse program: implications for public health.

Authors:  Denise Hallfors; Hyunsan Cho; Victoria Sanchez; Shereen Khatapoush; Hyung Min Kim; Daniel Bauer
Journal:  Am J Public Health       Date:  2006-06-29       Impact factor: 9.308

9.  Randomized controlled trials of induction treatment and surgery versus combined chemotherapy and radiotherapy in stages IIIA-N2 NSCLC: a systematic review and meta-analysis.

Authors:  Zuen Ren; Shijie Zhou; Zhidong Liu; Shaofa Xu
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

10.  Prevention of alcohol use in older teens: A randomized trial of an online family prevention program.

Authors:  Hilary F Byrnes; Brenda A Miller; Joel W Grube; Beth Bourdeau; David B Buller; Meme Wang-Schweig; W Gill Woodall
Journal:  Psychol Addict Behav       Date:  2019-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.